#374 - The evolutionary biology of testosterone: how it shapes male development and sex-based behavioral differences, | Carole Hooven, Ph.D.

What It Covers

Carole Hooven explains how prenatal testosterone exposure shapes male brain development and behavior patterns, creating sex differences in aggression, competition, and nurturing that persist despite modern social changes, while examining testosterone replacement therapy implications for both sexes.

Key Questions Answered

• •Prenatal testosterone window: Male fetuses experience testosterone levels around 400-600 ng/dL between weeks 8-20 of gestation, approaching puberty levels. This critical period masculinizes brain development through gene transcription on thousands of genes, creating behavioral differences observable in childhood despite minimal testosterone differences between boys and girls ages 3-10.
• •DHT and masculinization: The enzyme five alpha reductase converts testosterone to DHT locally in genital tissue, creating potent androgenic signals without systemic exposure. Men with five alpha reductase deficiency develop normal muscle mass and male behavior but lack facial hair and external male genitalia, proving DHT masculinizes anatomy but not brain or behavior.
• •Male aggression serves hierarchy: Rough physical play in boys teaches dominance hierarchy navigation, conflict resolution, and physical capability assessment. This reduces long-term aggression by establishing social order without constant fighting. Modern reduction in physical play may increase anxiety and social dysfunction by preventing this adaptive learning process during critical developmental windows.
• •Testosterone and fatherhood: Men living with young dependent children show measurable testosterone suppression, which facilitates nurturing behavior and pair bonding. This natural regulation optimizes reproductive success through paternal investment rather than mate seeking. Exogenous testosterone supplementation may override this adaptive response, though effects on parenting behavior require more research to quantify magnitude.
• •Androgen receptor density matters: Two men with identical 400 ng/dL testosterone levels can have vastly different symptoms based on androgen receptor density and CAG repeat length, which determines receptor efficiency. This explains why some men feel depleted at 400 while others function normally, making testosterone measurement alone insufficient for treatment decisions without considering individual receptor genetics.